|
||
Original Article |
Correspondence to: Robert Sackstein, Harvard Institutes of Medicine, 77 Ave. Louis Pasteur, Room 671, Boston, MA 02115. Tel:(617) 525-5601 Fax:(617) 525-5571 E-mail:rsackstein{at}rics.bwh.harvard.edu.
E-selectin plays a critical role in mediating tissue-specific homing of T cells into skin, and of primitive hematopoietic progenitor cells (HPCs) into bone marrow (BM). Though it is known that a glycoform of PSGL-1 (CLA) functions as the principal E-selectin ligand on human T lymphocytes, the E-selectin ligand(s) of human HPCs has not been identified. We used a shear-based adherence assay to analyze and define the E-selectin ligand activity of membrane proteins from human HPCs. Our data show that PSGL-1 expressed on human HPCs is an E-selectin ligand, and that HPCs also express a previously unrecognized E-selectin ligand, CD44. The E-selectin ligand activity of CD44 is conferred by the elaboration of sialylated, fucosylated binding determinants on N-glycans. This glycoform of CD44 is expressed on primitive CD34+ human HPCs, but not on more mature hematopoietic cells. Under physiologic flow conditions, this molecule mediates E-selectindependent rolling interactions over a wider shear range than that of PSGL-1, and promotes human HPC rolling interactions on E-selectin expressed on human BM endothelial cells. These findings offer new insights into the structural biology and physiology of CD44, and into the molecular basis of E-selectindependent adhesive interactions that direct homing of human HPC to BM.
Key Words: hematopoietic stem cells, E-selectin, CD44, PSGL-1, CLA
This article has been cited by other articles:
|
|